Concepedia

Author

Katharina Seystahl

University Hospital of ZurichORCID

Also Known As

J. T. Rutka, K Seystahl, K. Seystahl, Katharina Seystahl, the German Glioma Network

89

Publications

1.2K

Citations

18

H-Index

28

Concepts

All Affiliations

University Hospital of ZurichUniversity of ZurichInsermUniversité de LilleUniversity of St.Gallen
KS

About

Katharina Seystahl is an author at University Hospital of Zurich specializing in medicine, neuro-oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

85

2

Arts

1

1

19

3

Engineering

1

1

11

4

Health Sciences

1

1

14

5

Nursing

1

1

19

Katharina Seystahl

×

23

Publications

861

Citations

16

H-Index

YearCitations

Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to<sup>68</sup>Ga-DOTATATE/-TOC uptake

Katharina Seystahl, Veit M. Stoecklein, Ulrich Schüller,

Neuro-Oncology

2016

130

Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors

Émilie Le Rhun, Patrick Devos, Johannes Weller,

Neuro-Oncology

2020

112

Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo

Emese Szabó, Hannah Schneider, Katharina Seystahl,

Neuro-Oncology

2016

75

Differential regulation of TGF-β–induced, ALK-5–mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma

Katharina Seystahl, Isabel Tritschler, Emese Szabó,

Neuro-Oncology

2014

74

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma

Julia Furtner, Veronika Schöpf, Katharina Seystahl,

Neuro-Oncology

2015

66

Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma

Katharina Seystahl, Alexandros Papachristodoulou, Isabel Burghardt,

Molecular Cancer Therapeutics

2017

57

Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib

Nicole Hassold, Katharina Seystahl, Kristina Kempf,

International Journal of Cancer

2012

41

Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression

Raymond Y. Huang, Prashin Unadkat, Wenya Linda Bi,

Neuro-Oncology

2018

35

Limited role for transforming growth factor–β pathway activation-mediated escape from VEGF inhibition in murine glioma models

Davide Mangani, Michael Weller, Emad Seyed Sadr,

Neuro-Oncology

2016

33

Bevacizumab Alone or in Combination with Irinotecan in Recurrent WHO Grade II and Grade III Gliomas

Katharina Seystahl, Benedikt Wiestler, Thomas Hundsberger,

European Neurology

2012

28

Page 1